Strategic Sales Manager Health Care, H. ESSERS
T: +32 89 36 91 94
M: +32 498 51 15 77
Individual Medication Preparation (IMP) is a process whereby medication, individualized per patient on the basis of a current medication program, is prepared by a pharmacist (RD 24.09.2012) The process has made steady progress in healthcare in recent years, considering that it offers a number of important advantages to all parties involved in the process, not to mention the person needing care himself. If correctly implemented, IMP extends the self-reliance of vulnerable persons needing care who live at home thanks to proper use of medicine, increased therapy compliance and patient safety. This is one of the innovation objectives of the project.
Ambulant IMP is on the rise in home healthcare. In ambulant IMP, local pharmacists provide sets of medication to vulnerable people needing care who live at home, or IMP patients. The role of the pharmacist in this must be developed and determined further. Providing IMP for ambulant patients, however, is a logical step in the development of the profession of pharmacists because it answers to the will to offer high-quality care with an added value for the patient.
If applied manually, however, IMP is a labor intensive and expensive process that comes with no guarantee that it will work without error. There are significant barriers to applying IMP in an ambulant manner. Should the process be automated, the result is usually a rigid and non-flexible system with significant limitations that furthermore demand significant investment from the parties involved. For this reason, it is only available in an automated form for large organizations (i.e., hospital networks) and not for local pharmacists.
Objective and valorization
The IMP project aims to realize the advantages of both approaches with a single solution by means of a semi-automatic concept: a flexible, cost-efficient and mistake-free concept that can be used locally by pharmacists. Furthermore, by means of this concept, the pharmacist can spend less time on the technical act of IMP and thereby raise the quality of care.
IMP – if set up properly - can effectively lead to cost savings for the organizations and groups that are active in healthcare and for the authorities in general. One of the innovation objectives of the project is to demonstrate this.
The living lab project “IMP for the vulnerable person needing care who lives at home” is thus in the first instance intended for ambulant healthcare, i.e., offering IMP sets to vulnerable people needing care who live at home via the local pharmacist. Central to the project are the requirements and needs of the vulnerable person in need of care who lives at home concerning IMP so that the self-reliance of the vulnerable person needing care can be extended.
The starting point is that these needs can be fulfilled with the help of an innovative 'Supply Chain' process whereby medicines can be conditioned in 2 steps. The 1st step of the process will be conducted at a central location. The pharmacist can conduct the 2nd step locally. This innovative 'Supply Chain' process enables the pharmacist to effectively offer high-quality, personalized and user-friendly IMP sets to vulnerable people needing care who live at home in a safe and reliable manner and in a way that realizes cost savings.
Within the main group of vulnerable people needing care who live at home it will thereby aim at 2 specific populations in the Genk/Hasselt region: Patients with type 2 diabetes and informal caregivers of people with dementia needing care who live at home.